Towards Healthcare
Pharmaceutical Testing Services Market Grows USD 11.58 Bn by 2034

Pharmaceutical Testing Services Market 2025 to 2034 North America Leads, Asia Pacific Booms, AI Testing on the Rise

According to market projections, the pharmaceutical testing services sector is expected to grow from USD 4.27 billion in 2024 to USD 11.58 billion by 2034, reflecting a CAGR of 10.54%.Due to accelerating heavy investments in R&D and demand for biologics, biosimilars are fueling the global market growth. In this global market, North America dominated the market with a raised focus on bioanalytical testing and enhanced healthcare spending.

Content

  • Insight Code: 5937
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The pharmaceutical testing services market is projected to reach USD 11.58 billion by 2034, growing at a CAGR of 10.54% from 2024 to 2034.

North America is currently leading the pharmaceutical testing services market due to rising focus on bioanalytical testing services, with an increasing emphasis on healthcare expenses.

The pharmaceutical testing services market includes 5 segments such as by service type, by molecule type, by phase, by end-use, and by region.

Key trends include accelerating demand for drug discovery and personalized medicine, growth in biologics and biosimilars, and innovation in analytical testing and clinical trials.

The analytical techniques for drug analysis include optical methods, electrochemical methods, chromatography, electrophoresis, enzymatic methods, and immune methods.

NIH, US FDA, PIB, GOV.UK, CDSCO, SUGAM LABS, IPC, NBL, NHM
Any Questions